Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients

Assiut University79 enrolled

Overview

This study aims to assess ECG changes for predicting ventricular arrhythmia in cardiomyopathic patients

This study aims to assess ECG markers based on 24-hour Holter ECG recordings for predicting ventricular arrhythmia in patients with Structural Heart disease who have left ventricular dysfunction and Left Ventricular Ejection Fraction ≤40%. With special concerns to underlying structural abnormalities in cardiomyopathic patients using Cardiac Magnetic Resonance to determine ventricular function, scar distribution, and grey zone analysis

Study Type

OBSERVATIONAL

Enrollment

Conditions

Premature Ventricular Complex

Interventions

Holter monitoringDEVICE

24 hours Holter monitoring

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with ischemic and non-ischemic cardiomyopathy, EF \< 40 % * Patient haemodynamically stable * Patients accept to make test Exclusion Criteria: 1. Patients with underlying arrhythmia ex heart block or atrial arrhythmia like PACs, AF. 2. Patients on arrhythmogenic drugs ex digitalis, amiodarone. 3. Patients on underlying Pacemaker device or CRT-D. 4. Patients with MI in less than 40 days 5. Patients refuse to make test .

Outcomes

Primary Outcomes

Twenty-four hours Holter monitoring after Magnetic Resonance Imaging

24 Holter monitoring to detect PVCs burden which is defined as ≥10% of total beats

Time frame: One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.